Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function.

Mazzolai, L.; Ageno, W.; Alatri, A.; Bauersachs, R.; Becattini, C.; Brodmann, M.; Emmerich, J.; Konstantinides, S.; Meyer, G.; Middeldorp, S.; Monreal, M.; Righini, M.; Aboyans, V.

doi:10.1093/eurjpc/zwab088

Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function.

Details

Request a copy

Serval ID

serval:BIB_F5D5D4A9EECC

Type

Article: article from journal or magazin.

Collection

Publications

Institution

UNIL/CHUV

Title

Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function.

Journal

European journal of preventive cardiology

Author(s)

Mazzolai L., Ageno W., Alatri A., Bauersachs R., Becattini C., Brodmann M., Emmerich J., Konstantinides S., Meyer G., Middeldorp S., Monreal M., Righini M., Aboyans V.

ISSN

2047-4881 (Electronic)

ISSN-L

2047-4873

Publication state

Published

Issued date

27/05/2022

Peer-reviewed

Oui

Volume

Number

Pages

1248-1263

Language

english

Notes

Publication types: Journal Article
Publication Status: ppublish

Abstract

This consensus document is proposed to clinicians to provide the whole spectrum of deep vein thrombosis management as an update to the 2017 consensus document. New data guiding clinicians in indicating extended anticoagulation, management of patients with cancer, and prevention and management of post-thrombotic syndrome are presented. More data on benefit and safety of non-vitamin K antagonists oral anticoagulants are highlighted, along with the arrival of new antidotes for severe bleeding management.

Keywords

Anticoagulants/adverse effects, Aorta, Consensus, Humans, Peripheral Vascular Diseases, Pulmonary Circulation, Thrombolytic Therapy/adverse effects, Venous Thrombosis/diagnosis, Venous Thrombosis/drug therapy, Ventricular Function, Right, Anticoagulation, Cancer, Catheter-directed thrombolysis, Compression, Deep vein thrombosis, Diagnosis, Post-thrombotic syndrome, Pregnancy, Pulmonary embolism, Risk, Ultrasound

OAI-PMH

oai:serval.unil.ch:BIB_F5D5D4A9EECC

DOI

10.1093/eurjpc/zwab088

Pubmed

34254133

Web of science

000756615300001

Open Access

Yes

Create date

15/07/2021 15:16